VCN-01

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Eve Air Mobility (NYSE: EVEX) flies its eVTOL prototype for Brazilian authorities as certification work moves from concept to execution

Eve Air Mobility just flew its eVTOL for Brazil’s top officials. Is this the moment the air taxi race gets real?

Representative image of a leukemia drug development and biopharma acquisition theme, illustrating why Merck’s $6.7bn Terns Pharmaceuticals deal and TERN-701 are drawing attention as the Keytruda patent cliff approaches.

Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears

Representative image of an Infosys office building, reflecting the firm’s global push to scale Topaz as a full-stack generative AI transformation platform.

Why is Infosys buying Stratus now as insurance platform modernization enters an AI-heavy phase?

Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move

Could repeated VCN-01 dosing overcome long-standing survival barriers in metastatic PDAC?

Theriva Biologics advances VCN-01 into phase 3 for metastatic pancreatic cancer with FDA and EMA guidance. Discover what this means for trial execution and survival outcomes.

bySoujanya Ravi

March 26, 2026

Is viral vector therapy finally gaining traction in chemotherapy-resistant pediatric tumors?

Theriva’s APAO 2026 data shows viral–chemotherapy synergy in eye tumors. Find out what VCN-01 signals for pediatric oncology's biologics future.

bySoujanya Ravi

February 6, 2026

The Latest

Eve Air Mobility just flew its eVTOL for Brazil’s top officials. Is this the moment the air taxi race gets real?

Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears

Why is Infosys buying Stratus now as insurance platform modernization enters an AI-heavy phase?

Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move

Could repeated VCN-01 dosing overcome long-standing survival barriers in metastatic PDAC?

Is viral vector therapy finally gaining traction in chemotherapy-resistant pediatric tumors?

Eve Air Mobility just flew its eVTOL for Brazil’s top officials. Is this the moment the air taxi race gets real?

Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears

Why is Infosys buying Stratus now as insurance platform modernization enters an AI-heavy phase?

Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move

Boliden AB (STO: BOL) warns Garpenberg seismic damage will cut 2026 output and hit Q1 EBITDA

Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?

HICL Infrastructure (LSE: HICL) to sell A63 Motorway stake for £311m at 21% premium to book value

Atossa Therapeutics (NASDAQ: ATOS) deepens Z-endoxifen bet as 2025 losses widen and rare disease optionality grows